Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.To provide cGMP contract packaging services for select potent pharmaceutical compounds such as enzymes, antibiotics, antifolates, antimetabolites and some hormones
Subscribe to our email newsletter
Compass Pharma has completed a capital investment project to upgrade its production capabilities to include ISO Class 8 (ISO 14644) specifications, so as to provide packaging services for certain high-potency pharmaceutical products.
Reportedly, the capital improvements for ISO-Class 8 certification include a fully-integrated production suite, where the primary packaging area has negative differential air pressure relative to surrounding gowning and secondary packaging areas. High-Efficiency Particulate Air (HEPA) filters are deployed in the primary packaging area.
Tony Fenno, chief operating officer, Compass Pharma, said: “These capital improvements now allow us to provide cGMP contract packaging services for select potent pharmaceutical compounds such as enzymes, antibiotics, antifolates, antimetabolites and some hormones.”